Biotechnology is a field full of promise. But with expensive laboratory equipment and skilled instructors often in short supply, too few middle and high school students are able to develop the high-tech skills they need to pursue careers in this field.
That’s changing, thanks to the Amgen Biotech Experience (ABE), which works to advance STEM education in secondary schools across North America, Europe, and Asia Pacific. EDC operates the Program Office for ABE, providing a variety of essential functions—including technical assistance, resource development, and program site support—while helping to improve access to STEM education around the world.
- ABE has reached nearly 850,000 students across North America, Europe, and Asia Pacific.
- Each year, approximately 90,000 students and 1,500 science teachers participate in ABE.
- Preliminary research results show that ABE students have significant and substantial gains in both biotechnology learning and interest as well as confidence in doing science and biotechnology.
- ABE received a rating of “Accomplished” in the STEMworks database.
- In 2019–2020, 68% of the public schools participating in ABE in the United States were Title I schools.
ANISN (National Association of Natural Science Teacher), Biocom Institute, Carnegie Academy for Science Education, Chinese University of Hong Kong, Development Workshop, DNA-labs on the Road, Ecole Normale Supérieure, Harvard University, LA Promise Fund, San Diego Miramar College, Science Centre Singapore, Shoreline Community College, Technical University of Munich, The Citizen Science Lab, University College Dublin, University of California-Berkeley’s Lawrence Hall of Science, University of Hertfordshire, University of Puerto Rico-Humacao, University of Rhode Island, University of South Florida, University of Sydney, University of Tokyo, University of Toronto Mississauga